BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Singapore

GSK's Trelegy Ellipta Gets Singapore HSA Approval for Asthma, Expands Beyond COPD.

GSK Singapore announced that the Health Sciences Authority (HSA) has approved a new indication and a new strength for Trelegy Ellipta (fluticasone fur...

April 08, 2024 | News

ZEISS Acquires D.O.R.C., Eyeing Future Innovations in Ophthalmology

This acquisition, now fully approved by regulatory bodies, not only expands ZEISS's ophthalmic portfolio but also reinforces its standing as a trailb...

April 05, 2024 | News

From Silicon to Medicine: Steffen Lang Details Novartis' Digital Makeover in Singapore

Steffen Lang, President of Operations at Novartis, shares an insider's perspective with BioPharma APAC on the digital transformation and strategic expansio...

March 22, 2024 | News

A New Dawn in Heart Care: Singapore Leads with Innovative CVD Prevention Plan

In an interaction with BioPharma APAC, Dr. Low Lip Ping, Chairman Emeritus of the Singapore Heart Foundation, sheds light on the critical f...

March 20, 2024 | Interaction

Singapore Approves Everest Medicines' NEFEGAN® for Adult Primary IgA Nephropathy

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commerc...

March 20, 2024 | News

WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Facility in Singapore

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced ...

March 19, 2024 | News

BioNTech Amplifies Singapore's Biopharma Innovation with BioPIPS Entry

Singapore's biopharmaceutical landscape has taken a significant leap forward with the expansion of the Biologics Pharma Innovation ...

March 18, 2024 | News

Novartis Invests $256 Million to Expand Biopharmaceutical Manufacturing in Singapore, Bolstering Asian Market Supply

Invests US$256 million to expand biopharmaceutical manufacturing facility in Singapore, addressing the soaring demand in the Asian market ...

March 15, 2024 | News

Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics

Hyphens Pharma International Limited (“Hyphens Pharma”, “凯帆药剂国际有限公司”, or the “Company”, and togeth...

March 13, 2024 | News

APPIS 2024: Driving Better Health in Asia, Middle East & Africa

The 4th annual Alliance & Partnerships for Patient Innovation & Solutions (APPIS) Summit will take place on Tuesday, March 19, and Wednesday, ...

March 13, 2024 | News

Glen Godresse Charts a New Course for Menarini Asia-Pacific: A Vision of Growth Through Patient-Centric Innovation

BioPharma APAC sits down with Glen Godresse, the newly appointed Chief Executive Officer of Menarini Asia-Pacific, to discuss his strategic vision for the ...

March 13, 2024 | Interview

LogiPharma Asia is back for its 3rd edition this June 2024

This distinguished summit is uniquely positioned for global decision-makers and Asia-based supply chain leaders from world-leading pharmaceutical a...

March 06, 2024 | News

Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy

Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...

March 06, 2024 | News

Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific

Menarini Asia-Pacific is thrilled to announce the appointment of Glen Godresse as the company's Chief Executive Officer, effective March 1st, 2024. Bringin...

March 01, 2024 | News

Stay Connected